Nasdaq Expands Market Benchmarks with Real-Time Volatility Control Tools
New York, Sunday, 13 September 2026.
On September 14, 2026, Nasdaq launches a new index targeting 10% volatility, adjusting real-time tech exposure using intraday risk-management controls without disclosing component weightings.
Volatility Control Mechanism
The newly announced Nasdaq-100 Intraday 10% Edge Growth Index employs an intraday volatility control mechanism to adjust exposure to the Component based on contemporaneous realized volatility estimates [1]. This strategy is designed to provide exposure to an excess return strategy based on the Nasdaq-100 Total Return Index while targeting a 10% level of volatility [1]. Data recipients will receive real-time index information from the proprietary GIDS data feed starting on the effective date [1].
Data Transparency Policies
Regarding transparency, Nasdaq will not provide components for the index, distinguishing it from other benchmark products [1]. This stands in contrast to previous index launches where components and weightings data were made available for access via the Nasdaq Global Index Watch [2]. Investors seeking detailed weighting information for this specific product will need to rely on the aggregated data provided through the GIDS data feed [1].
Recent Product Cadence
The speed of deployment is notable, with this launch occurring just 4 days after the September 10th, 2026 dissemination of three new indexes [1][2]. Those earlier indexes included the Nasdaq-100 EUR Net Total Return Decrement Indexes, which began dissemination on Thursday, September 10th, 2026 [2]. This rapid succession highlights an aggressive expansion of the market benchmark suite within the same month [1][2].
Regulatory Context
This expansion aligns with broader product activity, including regulatory filings such as the VanEck JitoSOL ETF under Nasdaq Rule 5711(d) [3]. The Securities and Exchange Commission recently extended the decision period for such proposals by 60 days from the original 180-day period [3]. These regulatory timelines indicate a complex environment for new financial product approvals during this period [3].